Assertio Holdings Inc (NAS:ASRT)
$ 1.255 -0.03 (-2.34%) Market Cap: 119.65 Mil Enterprise Value: 73.63 Mil PE Ratio: 0 PB Ratio: 0.90 GF Score: 66/100

Assertio Holdings Inc Acquisition of Spectrum Pharmaceuticals Inc - M&A Call Transcript

Apr 25, 2023 / 12:30PM GMT
Release Date Price: $5.37 (-16.09%)
Operator

Good morning, and welcome to the Assertio Holdings, Inc. and Spectrum Pharmaceuticals, Inc. Conference Call. (Operator Instructions) Please note that this event is being recorded. I would now like to turn the conference over to Matt Kreps from Darrow Associates, Investor Relations for Assertio. Please go ahead.

Matthew Kreps
Darrow Associates Inc. - MD of IR

Thank you, Brianna. Good morning, and thank you to all of you for joining us on this special conference call regarding the definitive agreement announced earlier today, pursuant to which Assertio will acquire all outstanding shares of Spectrum and all stock and contingent value rights transaction. The joint press release with details of the agreement is now available on the investor pages of both companies. I would encourage you to review the release and related SEC filings. With me today are Dan Peisert, President and CEO of Assertio and Tom Riga, President and CEO of Spectrum. After prepared remarks from Dan and Tom, we will open the call for your questions. During this call, management will make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot